Anthony Puopolo
General Practice · Milford, MANPI 1790775542
Payments from drug & device makers
Across 758 payments — averaging $2590.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$734K
- Biohaven Pharmaceutical Holding Company Ltd.$507K
- Biohaven Pharmaceuticals, Inc.$345K
- AbbVie$250K
- Pfizer$72K
- GSK$34K
- plus $22K from 1 others
Across 1 payment — averaging $1255.50 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pfizer$1K
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 35 | $733,731 |
| Biohaven Pharmaceutical Holding Company Ltd. | 345 | $507,097 |
| Biohaven Pharmaceuticals, Inc. | 52 | $344,933 |
| AbbVie | 33 | $250,158 |
| Pfizer | 277 | $71,647 |
| GSK | 7 | $34,141 |
| Janssen Research & Development, LLC | 9 | $22,067 |
How this compares
$1,963,773 in reported general payments places this provider in the 95th percentile of 2,391 general practice providers in Massachusetts.
Other general practice in Milford
- Ahmed AwadFall River$3.5M
- Athena PapasBoston$1.4M
- Mark MiznerBoston$603K
- Maged El-MaleckiArlington$375K
- Daniel HanBoston$281K
- Gerard KugelBoston$277K
- Paul SerranoEverett$254K
- Michael StoneBoston$209K
- Paul CaselleWilmington$186K
- J Steven TonelliNo Reading$117K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.